Observations on National Pharmacare from John-Paul Dowson, PDCI’s Director of Reimbursement Strategy.
News
04
Feb2019
17
Jan2019
The Office of the pan-Canadian Pharmaceutical Alliance (pCPA) assesses brand name drug products for public funding either collectively or individually ... Read More
20
Dec2018
New updates from pCODR are as follows:
Webinar on Clinician Input and Feedback Seminar
CADTH is hosting a webinar in collaboration ... Read More
12
Nov2018
INESSS has launched a modernized website that is more user-friendly and provides greater transparency. Some of the highlighted new features ... Read More
01
Oct2018
Did you or your organization submit written comments to the recent national pharmacare consultation? If so, PDCI has volunteered to ... Read More
28
Aug2018
***Participation Requested***
Sharing Responses to the National Pharmacare Public Consultation
Announced in the 2018 federal budget and chaired ... Read More
27
Aug2018
PMPRB published its 2017 annual report this week, recalling an eventful year (complete with proposed amendments to its overarching regulations, ... Read More
03
Jul2018
CADTH Publishes New CDR Guidelines & Therapeutic Review Process, providing Framework to Revise CDEC Recommendations
/ CADTH, What's New
Last week, CADTH shared its new Procedure and Submission Guidelines for the CADTH Common Drug Review document which combines ... Read More